Presentation
# 5

Main Page

6th Internet World Congress for Biomedical Sciences

IndexIndex
One-page version
Dynamic pages

Invited Symposium: The Therapeutic Potential of Phase II Enzyme Induction (4 Presentations in this Symposium)

Glutathione deficiencies exacerbate response to stroke.

Phyllis G. Paterson(1)
(1)University of Saskatchewan - Saskatoon. Canada

[ABSTRACT] [CENTRAL ROLE OF GLUTATHIONE IN STROKE] [MODULATION OF BRAIN GLUTATHIONE IN STROKE] [IMAGES] [CONCLUSIONS] [ACKNOWLEDGEMENTS] [BIBLIOGRAPHY] [Discussion Board]
CONCLUSIONS Previous: Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. BIBLIOGRAPHY
Next: Can Dietary Phase II Enzyme Inducers Ameliorate Diseases With An Underlying Chronic Inflammatory Component To Them?

ACKNOWLEDGEMENTS

I thank the Heart and Stroke Foundation of Saskatchewan for funding my research.

Discussion Board
Discussion Board

Any Comment to this presentation?

[ABSTRACT] [CENTRAL ROLE OF GLUTATHIONE IN STROKE] [MODULATION OF BRAIN GLUTATHIONE IN STROKE] [IMAGES] [CONCLUSIONS] [ACKNOWLEDGEMENTS] [BIBLIOGRAPHY] [Discussion Board]
CONCLUSIONS Previous: Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. BIBLIOGRAPHY
Next: Can Dietary Phase II Enzyme Inducers Ameliorate Diseases With An Underlying Chronic Inflammatory Component To Them?
Phyllis G. Paterson
Copyright © 1999-2000. All rights reserved.
Last update: 13/01/00